-
TBPH Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Theravance Biopharma (TBPH)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 24.21 mm | 24.21 mm | 24.21 mm | 24.21 mm | 24.21 mm | 24.21 mm |
Cash burn (monthly) | 7.66 mm | 4.03 mm | 3.61 mm | 3.67 mm | 1.73 mm | 957.25 k |
Cash used (since last report) | 30.79 mm | 16.19 mm | 14.53 mm | 14.74 mm | 6.97 mm | 3.85 mm |
Cash remaining | -6.58 mm | 8.02 mm | 9.69 mm | 9.47 mm | 17.25 mm | 20.36 mm |
Runway (months of cash) | -0.9 | 2.0 | 2.7 | 2.6 | 10.0 | 21.3 |
13F holders | Current |
---|---|
Total holders | 119 |
Opened positions | 13 |
Closed positions | 26 |
Increased positions | 40 |
Reduced positions | 42 |
13F shares | Current |
---|---|
Total value | 356.08 bn |
Total shares | 45.77 mm |
Total puts | 12.80 k |
Total calls | 200.00 |
Total put/call ratio | 64.0 |
Largest owners | Shares | Value |
---|---|---|
Madison Avenue Partners | 9.51 mm | $76.66 bn |
Weiss Asset Management | 7.46 mm | $60.10 bn |
Newtyn Management | 4.50 mm | $36.26 bn |
BlackRock | 3.73 mm | $30.07 bn |
Irenic Capital Management | 2.76 mm | $22.25 bn |
Vanguard | 2.05 mm | $16.54 bn |
Park West Asset Management | 1.86 mm | $15.02 bn |
STT State Street | 1.19 mm | $9.60 bn |
Oasis Management | 1.12 mm | $8.99 bn |
Camber Capital Management | 1.00 mm | $8.06 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
21 Jan 25 | Rhonda Farnum | Ordinary Shares | Sell | Dispose S | No | No | 9 | 4,000 | 36.00 k | 309,565 |
20 Nov 24 | Rhonda Farnum | Ordinary Shares | Payment of exercise | Dispose F | No | No | 9.97 | 9,178 | 91.50 k | 313,565 |
20 Nov 24 | Aziz Sawaf | Ordinary Shares | Payment of exercise | Dispose F | No | No | 9.97 | 8,477 | 84.52 k | 312,889 |
20 Nov 24 | Brett A. Grimaud | Ordinary Shares | Payment of exercise | Dispose F | No | No | 9.97 | 9,268 | 92.40 k | 333,345 |
20 Nov 24 | Aine Miller | Ordinary Shares | Payment of exercise | Dispose F | No | No | 9.97 | 10,076 | 100.46 k | 150,556 |